News thumbnail
Top / Mon, 27 Jul 2026 EMJ

Children’s Respiratory Infections Rebounded After COVID-19

Respiratory infections caused by influenza viruses and Mycoplasma pneumoniae returned to pre-pandemic circulation patterns after COVID-19 restrictions were lifted, according to a large retrospective. Across the study period, investigators identified 16,042 influenza A infections, 3,728 influenza B infections, and 82,760 M. pneumoniae infections. Respiratory Pathogens Resurged After Restrictions EndedDuring periods of strict COVID-19 restrictions, detection rates for influenza A, influenza B, and M. pneumoniae remained consistently low. Influenza A infections peaked in March 2023, while M. pneumoniae infections reached their highest levels in November 2023. As respiratory pathogens continue to readjust to the post-pandemic environment, monitoring these trends may help healthcare systems better prepare for future epidemics and optimise paediatric respiratory disease control.

Respiratory infections caused by influenza viruses and Mycoplasma pneumoniae returned to pre-pandemic circulation patterns after COVID-19 restrictions were lifted, according to a large retrospective. The findings highlight the lasting impact of pandemic control measures on respiratory pathogen transmission and underscore the importance of continued surveillance in children.

Non-pharmaceutical interventions introduced during the COVID-19 pandemic, including mask wearing, school closures, social distancing, and enhanced hygiene practices, dramatically reduced the spread of many respiratory pathogens worldwide. However, less is known about how these infections have re-emerged following the relaxation of restrictions, particularly in paediatric populations.

More Than 400,000 Children Included

Researchers analysed electronic health records from children presenting with respiratory symptoms at a hospital in northwest China between January 2020 and December 2024.

A total of 169,757 children underwent testing for influenza A (IAV) and influenza B (IBV), while 412,015 were tested for Mycoplasma pneumoniae antibodies.

Across the study period, investigators identified 16,042 influenza A infections, 3,728 influenza B infections, and 82,760 M. pneumoniae infections. Detection rates differed significantly between years, reflecting the changing impact of pandemic control measures on respiratory pathogen circulation.

Respiratory Pathogens Resurged After Restrictions Ended

During periods of strict COVID-19 restrictions, detection rates for influenza A, influenza B, and M. pneumoniae remained consistently low.

Following the easing of public health measures, however, respiratory pathogens rapidly re-emerged. Influenza A infections peaked in March 2023, while M. pneumoniae infections reached their highest levels in November 2023.

The findings suggest that reduced circulation during the pandemic was followed by a substantial rebound once opportunities for transmission increased.

Age and Seasonal Patterns Persisted

The study also found that infection rates differed significantly according to both age and season.

Although influenza A and M. pneumoniae largely returned to age-related and seasonal patterns similar to those observed during the pandemic period, influenza B demonstrated modest shifts in its epidemiological profile after restrictions were lifted.

These findings indicate that while respiratory pathogens resumed circulation, individual organisms may respond differently to changes in population immunity and public health measures.

Continued Surveillance Remains Essential

The authors conclude that influenza viruses and Mycoplasma pneumoniae have re-established epidemic circulation among children following the relaxation of COVID-19 restrictions.

They suggest that ongoing epidemiological surveillance will be essential for identifying changing transmission patterns, anticipating seasonal outbreaks, and informing vaccination and infection prevention strategies. As respiratory pathogens continue to readjust to the post-pandemic environment, monitoring these trends may help healthcare systems better prepare for future epidemics and optimise paediatric respiratory disease control.

© All Rights Reserved.